Inecalcitol is an analog of calcitriol and a vitamin D3 receptor (VDR) agonist, primarily studied for its potential antineoplastic activity. It binds to and activates VDR, modulating gene expression that may influence cellular differentiation, apoptosis, and tumor cell growth inhibition.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 163217-09-2
Dexamethasone 7,9-diene
pharmaceutical raw material
Sodium chenodeoxycholate
pharmaceutical raw material
Norglipin
pharmaceutical raw material
Mesna
pharmaceutical raw material
Ezetimibe
pharmaceutical raw material
Ceritinib D7
pharmaceutical raw material
Sitafloxacin hydrate (2:3)
pharmaceutical raw material
((plusmn))-Zanubrutinib
pharmaceutical raw material
trans-(1R,3R)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylhept-4-yn-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
HHGRMHMXKPQNGF-WNSNRMDMSA-N
C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C